Delivery Order SPE2DB24D2106-SPE2DB25FAWPT
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,626.20 on August 11, 2025, for the supply of Fluticasone Propionate. The contract, which has an ultimate completion date of August 21, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order falls under the company's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,330.40 for Fluticasone Propionate under contract 8511430014. This firm fixed-price delivery order, awarded on June 9, 2025, with an ultimate completion date of June 19, 2025, is funded by the Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, allowing the vendor to compete on an open...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $1,035.90 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is a leading pharmaceutical wholesaler that provides a wide range of branded and generic pharmaceutical products to various U.S. government...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,664.64 to DMS Pharmaceutical Group Inc. for Fluticasone Propionate HFA 220 mcg inhalers (12-gram units) on September 8, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 9, 2025, was issued without a set-aside designation. The product will be delivered to Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,762.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564176703 - Fluticasone Prop HFA 110 MCG 12GM, with an ultimate completion date of April 5, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract number SPE2DB24FSX13, which has a...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,201.74 firm fixed-price contract is for the delivery of the drug fluticasone propionate, with a completion date of February 7, 2024. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, SPE2DB, with the Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,096.27 firm fixed-price delivery order is for the supply of Fluticasone Propionat, a pharmaceutical product, with a completion date of May 1, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,089.09 contract is for the supply of Fluticasone Propionat, a pharmaceutical product, with a completion date of July 14, 2022. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,413.12, is for the delivery of pharmaceutical products, including fluticasone propionate, to support the recurring medical supply needs of military health facilities. The award is under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,398.24 contract is for the delivery of Fluticasone Propion, a prescription medication, with a completion date of June 19, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWPTDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,828.94 by the Defense Logistics Agency on September 19, 2025, for the supply of Fluticasone Propionate HFA 110 MCG in 12-gram units. The delivery order, which has an ultimate completion date of September 22, 2025, carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and effective through November 2026. The Defense Logistics Agency utilizes the SPE2DB program to procure a broad range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Fluticasone propionate is a corticosteroid medication commonly used in respiratory treatments, and this delivery order represents a routine pharmaceutical supply fulfillment under the larger indefinite delivery vehicle. DMS Pharmaceutical Group's established position as a key federal pharmaceutical supplier, demonstrated through its extensive portfolio of delivery orders covering diverse medical products from prescription medications to specialty biologics, positions the company as a critical component of the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/19/25 |